Proc Natl Acad Sci U S A 101:66570 Garcia-Gimenez JL, Markovic J, Dasi F, Queval G, Schnaubelt D, Foyer CH, Pallardo FV (2013) Nuclear glutathione
Body composition and sarcopenia concerns have generated moderate but rapidly growing publication volume
The SELECT trial findings revealed that non-diabetic, overweight, and obese adults taking semaglutide (2.4 mg) for more than three years are at 20% less risk of stroke, heart attack, or death due to cardiovascular events
Similar observations of lower T m values and broader transitions were made for design-evolved mutations from the 415 and 413 evolutions that do not function in the WT background (Supplementary Fig
The Tirzepatide Paradox: Too Much of a Good Thing